HIV News and Research

RSS

When treating malaria is a waste of money

Africa may fail to benefit from new and better drugs for malaria because of massive misdiagnosis of the disease by health workers and patients.

5 Apr 2005

DNA repair kit announced by scientists

A study by scientists at Sangamo BioSciences, Inc. has demonstrated the use of the Company's zinc finger DNA-binding protein (ZFP) technology to achieve highly efficient, permanent correction of a disease-causing gene in primary human cells.

5 Apr 2005

International commitment to reduce maternal and child deaths by 2015 will not be met

An international commitment to reduce maternal and child deaths by 2015 will not be met at the current pace unless rapid and coordinated action is taken now, the World Health Organization (WHO) has warned.

5 Apr 2005

HIV/AIDS impacts on population dynamics and economic growth

Top officials at the United Nations Commission on Population and Development, at its yearly meeting are focussing on the negative effects of HIV/AIDS on population dynamics, including population losses and decreased life expectancy, as well as the pandemic's links to increased extreme poverty, stalled economic growth and poor reproductive health in many parts of the world.

5 Apr 2005

Young people believe oral sex less likely to have negative social and emotional consequences

Young people believe that oral sex is less risky to their health and emotions than vaginal sex, more prevalent among teens their age and more acceptable among their peers. They are also more likely to try oral sex, according to a University of California, San Francisco (UCSF) study published in the April 2005 issue of Pediatrics.

4 Apr 2005

Discrimination against AIDS patients to be stopped in India

India's Health Minister Anbumani Ramadoss has told an AIDS conference that his government plans to introduce a law to stop discrimination against people infected with the deadly virus.

4 Apr 2005

Rabies, HIV, cancer and malaria could all be prevented with pills in the future

Rabies, HIV, cancer and malaria could all be prevented with pills in the future, if a new technique using specially modified viruses to deliver vaccines is adopted, according to scientists speaking today (Tuesday, 05 April 2005) at the Society for General Microbiology's 156th Meeting at Heriot-Watt University, Edinburgh.

4 Apr 2005

Glaxo's CEO must answer questions in AIDS drug patent piracy case

A California federal court has ruled that GlaxoSmithKline's (GSK) Chief Executive Officer, Jean-Pierre Garnier, must answer further questions in a deposition in a patent piracy lawsuit brought against the British drug giant over GSK's patent for AZT (Retrovir), the first AIDS drug.

4 Apr 2005

Oral sex not sex say teens

Many teenagers in the US do not regard oral sex as sex and one in five say they have experience of it.

4 Apr 2005

Tarvacin shows significant anti-viral activity

Peregrine Pharmaceuticals today announced that there will be two presentations, April 4 and 6, at the American Association of Immunologists (AAI) annual meeting in San Diego, California, indicating the anti-viral potential of its Tarvacin antibody. Dr. Melina Soares of The University of Texas Southwestern Medical Center at Dallas will present pre-clinical data titled "Targeting inside-out phospholipids on viruses in a guinea pig model of Lassa fever."

4 Apr 2005

UK sex clinics swamped

A study, by sexual health charity the Terrence Higgins Trust, reveals the true scale of Britain's sexual health crisis and says that two-thirds of clinics are turning away patients because they cannot cope with demand for treatment.

4 Apr 2005

New chemicals to inhibit HIV infection

In corporation with peers from the Mount Sinai School of Medicine, New York University, researchers from the University of Science and Technology of China (USTC), a CAS affiliate, have come up with new chemical inhibitors against HIV reproduction, marking a significant progress in the development of anti-AIDS drugs based on natural host resistance.

4 Apr 2005

Moderate aerobic exercise improves cardiovascular and nervous system function in HIV+ subjects

Researchers from Teachers College, Columbia University, and Coler Goldwater Specialty Hospital and Nursing Facility report that moderate aerobic exercise for 10 weeks, three times a week for 45 minutes each session significantly improved function of the nervous system and circulation in those with HIV disease.

3 Apr 2005

First UK cases of previously rare disease reported in gay men

A previously rare disease has been reported for the first time in the UK, Lymphograunuloma venereum (LGV) is a genital/anogenital bacterial infection caused by a particularly invasive strain of Chlamydia trachomatis.

3 Apr 2005

New drug approved for treating endometriosis

Drug manufacturer Pfizer announced today that the U.S. Food and Drug Administration (FDA) has given approval for the release of depo-subQ provera 104 to be prescribed for the management of pain associated with endometriosis, a gynecological condition that affects one in ten women of reproductive age.

30 Mar 2005

Drug-resistant HIV identified in New York

Health officials in New York say they have identified several patients who may have been infected with a rare strain of highly drug-resistant HIV, but whether the cases are related is uncertain at this stage.

30 Mar 2005

Primary health care providers should incorporate HIV testing into routine patient care for all sexually active individuals

Primary health care providers should incorporate human immunodeficiency virus (HIV) testing into routine patient care for all sexually active individuals, regardless of risk factors, say a group of physician/researchers at Emory University School of Medicine, Brown Medical School, and the Johns Hopkins School of Medicine.

30 Mar 2005

New drug to treat chronic hepatitis B

The U.S. Food and Drug Administration (FDA) has given approval for a new drug to treat the potentially life-threatening disease Chronic hepatitis B.

30 Mar 2005

HIV patients who delay seeking care are much sicker when they begin care

Patients recently diagnosed with human immunodeficiency virus (HIV) are significantly more likely to seek medical treatment if they are followed even briefly by a case manager, according to findings of the national Antiretroviral Treatment Access Study (ARTAS).

30 Mar 2005

REPLICor to disclose unique antiviral drug

REPLICor Inc., a privately owned biopharmaceutical company, is developing a broad spectrum antiviral drug called REP 9 which has the broadest spectrum of activity in vitro ever reported for a single chemical entity.

30 Mar 2005